Skip to main content
. 2023 May 30;44(6):975–1011. doi: 10.1210/endrev/bnad016

Table 2.

Systemic availability of different glucocorticoid formulations

Steroid formulation Bioavailability References
IV >90% 561-563
Oral 76-99% 561-567
Nasal First generation 40-50% 568
Second generation 10-34%
Third generation <2%
Inhaled 30-37% 569
Intra-articular N/A
Topical N/A

Abbreviations: IV, intravenous; N/A, not available.